Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Objective: To assess the efficacy and safety profiles of different dosing regimens of tofacitinib, baricitinib, and upadacitinib, novel selective oral Janus activated kinase inhibitors, in rheumatoid arthritis (RA).

Source: Mayo Clinic Proceedings - May 31, 2020 Category: Internal Medicine Authors: Faping Wang, Ling Sun, Shaohua Wang, John M. Davis, Eric L. Matteson, M. Hassan Murad, Fengming Luo, Robert Vassallo Tags: Original article Source Type: research